Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer
DALLAS, TEXAS AND OSS, THE NETHERLANDS – 4 November 2026 – Trained Therapeutix Discovery (“TTxD”), a pioneering immunotherapy company founded by the Jean Boulle Group…
DALLAS, TEXAS AND OSS, THE NETHERLANDS – 4 November 2026 – Trained Therapeutix Discovery (“TTxD”), a pioneering immunotherapy company founded by the Jean Boulle Group…
-Recognition highlights pioneering contributions to nanomedicine underpinning the company’s RIDE platform Oss, The Netherlands — April 14, 2026 — Trained Therapeutix Discovery, a biotechnology company…
DALLAS and OSS, The Netherlands, Feb. 09, 2026 (GLOBE NEWSWIRE) — Trained Therapeutix Discovery, a pioneering immunotherapy biotech company revolutionizing the treatment of immune-mediated diseases…
Trained Therapeutix Discovery Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual…
Trained Therapeutix Discovery Appoints Joost Kreijtz, PhD, as Chief Executive Officer of Dutch Subsidiary Trained Therapeutix Discovery (NL) Dallas, TX & The Netherlands — October…
Trained Therapeutix Discovery is pleased to announce its participation in BIO-Europe, taking place in Vienna from November 3 to 5, 2025. Our management team will…